ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease (SAPHIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02389413
Recruitment Status : Completed
First Posted : March 17, 2015
Last Update Posted : June 1, 2017
Sponsor:
Collaborators:
Julius Clinical
VU University Medical Center
Information provided by (Responsible Party):
Probiodrug AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2017
  Actual Study Completion Date : April 2017